NCT02099253View on ClinicalTrials.gov

The Influence of Age on Dexmedetomidine Pharmacodynamic

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Spinal Anesthesia
Interventions
DRUG

Dexmedetomidine 01

Initial doses was 1μg/kg, with dose adjustment intervals of 0.05μg/kg.

DRUG

Dexmedetomidine 02

Initial doses was 0.7μg/kg, with dose adjustment intervals of 0.05μg/kg.

Trial Locations (1)

510010

Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou

All Listed Sponsors
lead

Guangzhou General Hospital of Guangzhou Military Command

OTHER

NCT02099253 - The Influence of Age on Dexmedetomidine Pharmacodynamic | Biotech Hunter | Biotech Hunter